BPI 2026 · CDMO & CRO

Catalent at BPI 2026

Somerset, New Jersey

Catalent brings 2 presentations to BPI 2026 in Boston, and exhibits at Booth 1024. Its program covers AAV gene therapy development and supply resilience through risk-based thinking. One session lays out platform strategies that shorten the path to clinical readiness for AAV programs.

OrganizationBPI 2026 Attendance
Catalent
Somerset, New Jersey
1 Chief Commercial Officer · 1 Fellow Scientist
catalent.com
CDMO & CROGold sponsor
CDMO providing development, manufacturing and fill-finish for biologics, gene therapies and other drug products.
Booth
Exhibiting at Booth 1024
Wed, Sep 233:30pm–7:00pmThu, Sep 248:15am–5:00pmFri, Sep 259:00am–1:50pm
Talk
Thu Sep 24
12:30pm–1:00pm
Streamlining the Critical Path for AAV Gene Therapy Development: Platform Strategies to Accelerate Clinical Readiness
Development of Emerging Cell & Gene Therapies
Talk
Thu Sep 24
1:30pm–1:50pm
Advancing Supply Resilience Through Risk-Based Innovation
Innovation and Community Stage (Exhibit Hall)
CMC & Manufacturing Strategy

Explore the full BPI 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Boston. Leave your work email and we’ll be in touch.

Privacy

Download the full BPI 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Catalent

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by Informa Connect or the BioProcess International Conference & Exhibition. Submit a correction